1515 — China Resources Medical Holdings Cashflow Statement
0.000.00%
- HK$4.38bn
- HK$6.83bn
- CNY10.11bn
- 51
- 84
- 13
- 47
Annual cashflow statement for China Resources Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 541 | 418 | 270 | 423 | 493 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -12 | -99.8 | 216 | 153 | 493 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -227 | 212 | 40.7 | -198 | -401 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 366 | 644 | 710 | 864 | 1,195 |
Capital Expenditures | -36.4 | -210 | -227 | -466 | -487 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 194 | 270 | -1,709 | -27.7 | -2,135 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 157 | 60.4 | -1,936 | -494 | -2,622 |
Financing Cash Flow Items | 17.5 | -23.8 | -29.7 | -57.7 | -129 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -41 | -7.38 | 846 | -224 | -437 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 482 | 695 | -377 | 149 | -1,864 |